In Mali and many parts of Africa, the incidence of mycobacterial infection is very high and driven in large part by the overlapping HIV epidemic. Mycobacterium tuberculosis (MTB) and Mycobacterium africanum (MAF), both closely related members of the M.tuberculosis complex (MTBC), as well as non-tuberculous mycobacterium (NTM) cause human mycobacterial infections and disease in West Africa. MTBC has been widely studied; however, little is known about differences in pathogenesis, genetics, epidemiology, diagnosis, and management between MTB, MAF, and NTM among HIV-infected individuals. The University of Sciences, Techniques, and Technologies of Bamako, Mali (USTTB; University of Bamako) in collaboration with the Point- G and Gabriel Tour Teaching Hospitals in Bamako, are well equipped to build a translational research-training program in HIV-associated mycobacterial infection. The research team at USTTB has received substantial and continuous support from the NIH starting with its intramural malaria research program in the late 1980s. In 2005, this program was expanded to include HIV and tuberculosis research, which included development of a BSL-3 high containment laboratory capable of testing for mycobacterial drug resistance and testing for Ebola virus. NIAID has continuously supported the HIV and tuberculosis programs since its formation. In 2014, NIAID committed an additional 4 years of development support for the University Clinical Research Center (UCRC) in order to enhance clinical research opportunities. In our proposed program, we will continue developing HIV and mycobacterial research capacity at USTTB with established collaborators at Northwestern University, Johns Hopkins University and NIAID by leveraging ongoing research training efforts at these institutions to address each of the following aims: 1) produce and enhance the careers of Malian researchers capable of performing advanced research on the molecular biology, genetics, immunology, clinical investigation and microbiology of HIV-associated mycobacterial infection; 2) enhance and strengthen the graduate training programs at USTTB which focus on HIV infection and its mycobacterial co-morbidities through faculty enrichment and support of clinical and laboratory scientists; and 3) develop new intensive USTTB Diploma programs in retrovirology, HIV co-morbidities and mycobacteriology which will serve as core training programs for existing faculty and staff locally and from other low- and middle-income institutions throughout the region. Through this program, we will achieve the overall goal of training the next generation of investigators focused on HIV-associated mycobacterial infection who will be able to conduct HIV-related research on the evolving epidemic in Mali. We aspire to take USSTB investigators to the next level of research capacity and to make USSTB a center of excellence in the research and care of HIV and associated mycobacterial infections in West Africa.

Public Health Relevance

The HIV and Mycobacterial Disease Research Training Program in Mali will provide doctorate and post- doctorate clinical, laboratory, and translational research training opportunities to Malian physicians and scientists studying HIV-associated mycobacterial infections. The program will foster timely and clinically relevant research as well as expand established collaborations between researchers at the University of Sciences, Techniques and Technologies of Bamako, Northwestern University, and Johns Hopkins University.

Agency
National Institute of Health (NIH)
Institute
Fogarty International Center (FIC)
Type
International Research Training Grants (D43)
Project #
5D43TW010350-05
Application #
9878144
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Bansal, Geetha Parthasarathy
Project Start
2016-04-09
Project End
2021-02-28
Budget Start
2020-03-01
Budget End
2021-02-28
Support Year
5
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Northwestern University at Chicago
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
005436803
City
Chicago
State
IL
Country
United States
Zip Code
60611
Oumar, Aboubacar Alassane; Bagayoko-Maiga, Kadiatou; Bahachimi, Aliou et al. (2018) Efavirenz and Lopinavir Levels in HIV-Infected Women and Their Nursing Infants, in Mali. J Pharmacol Exp Ther 366:479-484
Kone, B; Sarro, Y S; Maiga, M et al. (2018) Clinical characteristics of non-tuberculous mycobacterial pulmonary infections in Bamako, Mali. Epidemiol Infect 146:354-358
Kone, Amadou; Diarra, Bassirou; Cohen, Keira et al. (2018) Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali. HLA :
Crowell, Claudia S; Maiga, Almoustapha I; Sylla, Mariam et al. (2017) High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali. Pediatr Infect Dis J 36:e258-e263
Kone, B; Maiga, M; Baya, B et al. (2017) Establishing Reference Ranges of Hematological Parameters from Malian Healthy Adults. J Blood Lymph 7:
Togo, Antieme Combo Georges; Kodio, Ousmane; Diarra, Bassirou et al. (2017) The most frequent Mycobacterium tuberculosis complex families in mali (2006-2016) based on spoligotyping. Int J Mycobacteriol 6:379-386
Sanogo, M; Kone, B; Diarra, B et al. (2017) Performance of microscopic observation drug susceptibility for the rapid diagnosis of tuberculosis and detection of drug resistance in Bamako, Mali. Clin Microbiol Infect 23:408.e1-408.e6
Brice, Josephine; Sylla, Mariam; Sayon, Sophie et al. (2017) Qualitative and quantitative HIV antibodies and viral reservoir size characterization in vertically infected children with virological suppression. J Antimicrob Chemother 72:1147-1151
Diarra, Bassirou; Toloba, Yacouba; Konate, Bakary et al. (2017) Extensively drug resistant tuberculosis in Mali: a case report. BMC Res Notes 10:561
Oumar, Aboubacar A; Diallo, Korotoumou; Dembélé, Jean P et al. (2012) Adverse drug reactions to antiretroviral therapy: prospective study in children in sikasso (mali). J Pediatr Pharmacol Ther 17:382-8